Carcinoma of the esophagus: Is biology screaming in my deaf ears?

Journal of Clinical Oncology

Volumn 23, Issue 19, 2005, Pages 4256-4258

  Ajani, Jaffer A ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUOROURACIL;

ALCOHOLISM; BARRETT ESOPHAGUS; BODY MASS; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CIGARETTE SMOKING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DISEASE ASSOCIATION; EDITORIAL; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS CANCER; ESOPHAGUS CARCINOMA; GASTROESOPHAGEAL REFLUX; HUMAN; LIFESTYLE; MORBIDITY; OVERALL SURVIVAL; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; RACE DIFFERENCE; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL; TREATMENT RESPONSE; CARCINOMA; ESOPHAGUS TUMOR; MORTALITY; MULTIMODALITY CANCER THERAPY; NOTE; PROGNOSIS; SURVIVAL RATE;

CARCINOMA; COMBINED MODALITY THERAPY; ESOPHAGEAL NEOPLASMS; HUMANS; PROGNOSIS; SURVIVAL RATE;

EID: 22344451169     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.12.911     Document Type: Editorial

References (9)

1. Wild CP, Hardie LJ: Reflux, Barrett's oesophagus and adenocarcinoma: Burning questions. Nat Rev Cancer 3:676-684, 2003
2. Z. Engel LS, Chow WH, Vaughan TL, et al: Population attributable risks of esophageal and gastric cancers. J Natl Cancer Inst 95:1404-1413, 2003
3. Devesa SS, Blot WJ, Fraumeni JF: Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 83:2049-2053, 1998
4. Berger AC, Farma J, Scott WJ, et al: Complete response to neoadjuvant chemoradiotherapy in esophageal carcinoma is associated with significantly improved survival. J Clin Oncol 23:4330-4337, 2005
5. Rohatgi P, Swisher SG, Correa AM, et al: Prediction of pathologic complete response after preoperative chemoradiotherapy in carcinoma of the esophagus and outcome after pathologic complete response. Cancer (in press)
6. Chiriec LR, Swisher SG, Ajani JA, et al: Posttherapy pathologic stage predicts survival in patients with esophageal carcinoma receiving preoperative chemoradiation. Cancer (in press)
7. Gibson M, Burtness B, Heath E, et al: Effect of neoadjuvant chemoradiotherapy on pathologic stage and survival in patients with locally advanced esophageal cancer. Proc Am Soc Clin Oncol 23:320, 2004 (abstr 4032)
8. Yang O, Cleary KR, Yao J, et al: Significance of post-chemoradiation biopsy in predicting residual esophageal carcinoma in the surgical specimen. Dis Esophagus 17:38-43, 2004
9. Agarwal B, Swisher SG, Ajani, et al: Endoscopic ultrasound after preoperative chemoradiation can help identify patients who benefit maximally after surgical esophageal resection. Am J Gastroenterol 99:1258-1266, 2004